189 related articles for article (PubMed ID: 16817795)
1. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
Ramunni A; Quaranta N; Saliani MT; Fallacara RA; Ria R; Ranieri G
Ther Apher Dial; 2006 Jun; 10(3):282-6. PubMed ID: 16817795
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial].
Suckfüll M; Seidel D; Thiery J; Mazurek B; Jaehne M; Gronemeyer J; Reichel O; Sasama J; Kichigina S; Möller M; Beil FU; Schrameyer-Wernecke A; Kassner U; Koch M; Jaeger B; Osterkorn K; Osterkorn D
Z Kardiol; 2003; 92(Suppl 3):III59-63. PubMed ID: 14663604
[TBL] [Abstract][Full Text] [Related]
3. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
Horstkotte D; Mellwig KP
Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
[TBL] [Abstract][Full Text] [Related]
4. [Hypercholesteremia and hyperfibrinogenemia in sudden deafness].
Suckfüll M; Thiery J; Wimmer C; Mees K; Schorn K
Laryngorhinootologie; 1997 Aug; 76(8):453-7. PubMed ID: 9376027
[TBL] [Abstract][Full Text] [Related]
5. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
Suckfüll M
Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
[TBL] [Abstract][Full Text] [Related]
6. Treatment with HELP-apheresis in patients suffering from sudden sensorineural hearing loss: a prospective, randomized, controlled study.
Bianchin G; Russi G; Romano N; Fioravanti P
Laryngoscope; 2010 Apr; 120(4):800-7. PubMed ID: 20213795
[TBL] [Abstract][Full Text] [Related]
7. [Apheresis decreases LDL and fibrinogen. Rapid treatment in sudden deafness].
MMW Fortschr Med; 2002 Apr; 144(15):64. PubMed ID: 12013034
[No Abstract] [Full Text] [Related]
8. Shear stress-dependent platelet function after LDL cholesterol apheresis.
Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of sudden sensorineural hearing loss (SSHL) with HELP-apheresis: our experience].
Russi G; Bianchin G; Romano N; Canovi L; Polizzi V; Scarano L
G Ital Nefrol; 2012; 29 Suppl 54():S138-40. PubMed ID: 22388846
[TBL] [Abstract][Full Text] [Related]
10. Is the efficacy of LDL apheresis in ischemic optic neuropathy linked to a reduction in endothelial activation markers?
Ramunni A; Ranieri G; Giancipoli G; Guerriero S; Ria R; Saliani MT; Sborgia L; Ranieri P; Coratelli P
Blood Purif; 2006; 24(4):405-12. PubMed ID: 16847390
[TBL] [Abstract][Full Text] [Related]
11. [H.E.L.P. therapy (heparin-induced extracorporeal LDL precipitation) in sudden deafness].
Walch C; Anderhuber W; Walzl M
Laryngorhinootologie; 1996 Nov; 75(11):641-5. PubMed ID: 9063830
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen/LDL apheresis as successful second-line treatment of sudden hearing loss: a retrospective study on 217 patients.
Heigl F; Hettich R; Suckfuell M; Luebbers CW; Osterkorn D; Osterkorn K; Canis M
Atheroscler Suppl; 2009 Dec; 10(5):95-101. PubMed ID: 20129384
[TBL] [Abstract][Full Text] [Related]
13. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis.
Ullrich H; Kleinjung T; Steffens T; Jacob P; Schmitz G; Strutz J
J Clin Apher; 2004; 19(2):71-8. PubMed ID: 15274199
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial.
Suckfüll M;
Lancet; 2002 Dec; 360(9348):1811-7. PubMed ID: 12480357
[TBL] [Abstract][Full Text] [Related]
15. LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis.
Kobayashi S; Oka M; Moriya H; Maesato K; Okamoto K; Ohtake T
Ther Apher Dial; 2006 Jun; 10(3):219-23. PubMed ID: 16817784
[TBL] [Abstract][Full Text] [Related]
16. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
Otto C; Berster J; Otto B; Parhofer KG
J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
[TBL] [Abstract][Full Text] [Related]
17. Rheopheresis for sudden sensorineural hearing loss.
Klingel R; Heibges A; Uygun-Kiehne S; Fassbender C; Mösges R
Atheroscler Suppl; 2009 Dec; 10(5):102-6. PubMed ID: 20129385
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen is not a prognostic factor for response to HELP-apheresis in sudden sensorineural hearing loss (SSHL).
Berger T; Kaiser T; Scholz M; Bachmann A; Ceglarek U; Hesse G; Hagemeyer B; Stumvoll M; Thiery J; Dietz A
Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3693-703. PubMed ID: 25527412
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of DALI LDL-apheresis at high blood flow rates: a prospective multicenter study.
Wendler T; Schilling R; Lennertz A; Sodemann K; Kleophas W; Messner H; Riechers G; Wagner J; Keller C; Bosch T
J Clin Apher; 2003; 18(4):157-66. PubMed ID: 14699591
[TBL] [Abstract][Full Text] [Related]
20. [H.E.L.P. apheresis and oxidative stress].
Pulawski E; Mellwig KP; Horstkotte D
Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
